Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-04
DOI
10.1038/s41467-020-14340-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mousetap, a Novel Technique to Collect Uncontaminated Vitreous or Aqueous and Expand Usefulness of Mouse Models
- (2018) Seth D. Fortmann et al. Scientific Reports
- Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration
- (2016) Maureen G. Maguire et al. OPHTHALMOLOGY
- Diabetic Retinopathy Severity and Peripheral Lesions Are Associated with Nonperfusion on Ultrawide Field Angiography
- (2015) Paolo S. Silva et al. OPHTHALMOLOGY
- Long-Term Outcomes in Eyes Receiving Fixed-Interval Dosing of Anti–Vascular Endothelial Growth Factor Agents for Wet Age-Related Macular Degeneration
- (2015) Marc C. Peden et al. OPHTHALMOLOGY
- Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
- (2014) Frank G Holz et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Neutralization of Vascular Endothelial Growth Factor Slows Progression of Retinal Nonperfusion in Patients with Diabetic Macular Edema
- (2014) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Ten-Year Follow-up of Age-Related Macular Degeneration in the Age-Related Eye Disease Study
- (2014) Emily Y. Chew et al. JAMA Ophthalmology
- Long-term Outcomes in Ranibizumab-Treated Patients With Retinal Vein Occlusion; The Role of Progression of Retinal Nonperfusion
- (2013) Raafay Sophie et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
- (2013) Juan E. Grunwald et al. OPHTHALMOLOGY
- Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death
- (2013) D. S. Welsbie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-term Effects of Ranibizumab on Diabetic Retinopathy Severity and Progression
- (2012) Michael S. Ip ARCHIVES OF OPHTHALMOLOGY
- Drug Absorption Interactions Between Oral Targeted Anticancer Agents and PPIs: Is pH-Dependent Solubility the Achilles Heel of Targeted Therapy?
- (2012) N R Budha et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Global Prevalence and Major Risk Factors of Diabetic Retinopathy
- (2012) J. W. Y. Yau et al. DIABETES CARE
- Intraocular distribution of melanin in human, monkey, rabbit, minipig and dog eyes
- (2012) Chandrasekar Durairaj et al. EXPERIMENTAL EYE RESEARCH
- HORIZON: An Open-Label Extension Trial of Ranibizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
- (2012) Michael A. Singer et al. OPHTHALMOLOGY
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Ranibizumab for Diabetic Macular Edema
- (2012) Quan Dong Nguyen et al. OPHTHALMOLOGY
- Vascular Endothelial Growth Factor Promotes Progressive Retinal Nonperfusion in Patients with Retinal Vein Occlusion
- (2012) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study
- (2011) David M. Brown et al. OPHTHALMOLOGY
- Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study
- (2011) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion
- (2010) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Ranibizumab for Macular Edema following Central Retinal Vein Occlusion
- (2010) David M. Brown et al. OPHTHALMOLOGY
- Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
- (2010) Michael J. Elman et al. OPHTHALMOLOGY
- Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
- (2009) Quan Dong Nguyen et al. OPHTHALMOLOGY
- Ranibizumab for Macular Edema Due to Retinal Vein Occlusions: Implication of VEGF as a Critical Stimulator
- (2008) Peter A Campochiaro et al. MOLECULAR THERAPY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started